EMC
54
-4
PX
19
3
HON
55
2
USB
39
2
DOW
46
2
MRO
40
-2
DD
67
15
GE
67
-3
SEE
48
4
DO
54
2
GIS
58
-3
KEY
37
3
JCI
38
-12
CHK
24
-10
PFE
33
10
FMC
39
-2
TXT
68
2
FITB
58
3
HCP
84
-2
DTE
45
3
EMC
54
-4
PX
19
3
HON
55
2
USB
39
2
DOW
46
2
MRO
40
-2
DD
67
15
GE
67
-3
SEE
48
4
DO
54
2
GIS
58
-3
KEY
37
3
JCI
38
-12
CHK
24
-10
PFE
33
10
FMC
39
-2
TXT
68
2
FITB
58
3
HCP
84
-2
DTE
45
3
Financhill
Back

Bolt Biotherapeutics 10K Form

Sell
31

BOLT
Bolt Biotherapeutics

Last Price:
1.10
Seasonality Move:
-8.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BOLT News And Ratings

See the #1 stock for the next 7 days that we like better than BOLT

BOLT Financial Statistics

Sales & Book Value

Annual Sales: $7.88M
Cash Flow: $-14.27M
Price / Cash Flow: 0
Annual Sales: $2.96
Price / Book: 0.37

Profitability

EPS (TTM): -1.83000
Net Income (TTM): $-69.2M
Gross Margin: $34.4M
Return on Equity: -48.57%
Return on Assets: -36.05%

Bolt Biotherapeutics Earnings Forecast

Key Bolt Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 10 years for BOLT is 50.96%.
  • The Selling, General & Administrative Expenses for BOLT have been equal to 286.06% of Gross Profit Margin.
  • The Research & Development expenses have been 781.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BOLT is -878.58% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

Bolt Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BOLT
Website: boltbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.17
Quick Ratio: 5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BOLT Technical Analysis vs Fundamental Analysis

Sell
31
Bolt Biotherapeutics (BOLT) is a Sell

Is Bolt Biotherapeutics a Buy or a Sell?